Antihypertensive
Pregnancy: C — neonatal bradycardia and growth restriction risk
Propranolol (Portal Hypertension)
Brand names: Inderal, Angilol
Adult dose
Dose: Primary prophylaxis varices: 40–80mg BD (titrate to reduce HR by 25% or to HR 55–60 bpm)
Route: Oral
Frequency: Twice daily
Max: 320mg/day
Portal hypertension: non-selective beta-blocker reduces portal pressure by reducing cardiac output and splanchnic vasodilation. Titrate to resting HR 55–60 bpm or 25% reduction from baseline. Check endoscopy results — carvedilol (6.25mg BD) has better portal pressure reduction.
Dose adjustments
Renal
No adjustment required.
Hepatic
Reduce dose — reduced hepatic metabolism in cirrhosis. Increased bioavailability and risk of accumulation.
Clinical pearls
- Non-selective beta-blockers (propranolol, nadolol, carvedilol) reduce portal hypertension via reduction of cardiac output AND splanchnic vasoconstriction (β₂ block).
- BAVENO VII recommendations: carvedilol 6.25mg BD preferred over propranolol — superior reduction in HVPG (hepatic venous pressure gradient).
- Prophylaxis of first variceal bleed: propranolol or band ligation (EVL). Combination not superior.
- Spontaneous bacterial peritonitis: propranolol may paradoxically worsen outcomes in advanced cirrhosis with refractory ascites — reassess risk/benefit.
Contraindications
- Asthma (non-selective beta-blockade — bronchospasm)
- Second or third degree AV block
- Peripheral vascular disease (severe — worsens limb ischaemia)
- Porphyria
Side effects
- Bradycardia, hypotension
- Cold extremities
- Fatigue, nightmares (CNS penetration)
- Bronchospasm (non-selective — contraindicated in asthma)
- Masking of hypoglycaemia in diabetes
Interactions
- Verapamil / diltiazem: severe bradycardia and AV block
- Adrenaline: paradoxical hypertension then severe bradycardia
- Hypoglycaemic agents: masks hypoglycaemia symptoms
Monitoring
- Resting HR (target 55–60 bpm)
- BP
- signs of HF or bronchospasm
- compliance
Reference: BAVENO VII Consensus 2022; BSG Portal Hypertension Guidelines; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- REVEAL 2.0 Risk Score for Pulmonary Arterial Hypertension · Pulmonary Hypertension
- AUB-HAS2 Cardiovascular Risk Index · Cardiovascular Risk
- RV Systolic Pressure Estimation (RVSP) · Echocardiography
- TAPSE for RV Systolic Function · Echocardiography
- WHO Functional Classification (Pulmonary Hypertension) · Pulmonary Hypertension
- Pheochromocytoma Clinical Probability (10% Rule) · Adrenal Disorders
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021